Skip to main content
. 2016 Oct 12;67(2):291–298. doi: 10.1136/gutjnl-2016-312712

Table 1.

Demographic and clinical characteristics of patients who died from colorectal cancer and matched controls

Characteristics, n (%) Cases (n=1747) Controls (n= 3460)
Used for case–control matching
Age at diagnosis, years*
 50–54 23 (1.3) 65 (1.9)
 55–64 570 (32.6) 1107 (32.0)
 65–74 504 (28.8) 983 (28.4)
 75–84 556 (31.8) 1103 (31.9)
 85–89 94 (5.4) 202 (5.8)
Female 883 (50.5) 1756 (50.8)
Study sites
 KPNC 1443 (82.6) 2881 (83.3)
 KPSC 304 (17.4) 579 (16.7)
Length of enrolment with health plan before reference date, years
 5.0–7.4 304 (17.4) 600 (17.3)
 7.5–9.9 315 (18.0) 636 (18.4)
 ≥10 1128 (64.6) 2224 (64.3)
Characteristics not used for matching
Race ethnicity
 Non-Hispanic white 1170 (67.0) 2318 (67.0)
 Non-Hispanic black 208 (11.9) 244 (7.1)
 Hispanic 164 (9.4) 374 (10.8)
 Asian/Pacific Islander 156 (8.9) 397 (11.5)
 Other/unknown 49 (2.8) 127 (3.7)
Per cent with at least a high school diploma, quartiles†
 1 374 (21.4) 871 (25.2)
 2 419 (24.0) 873 (25.2)
 3 435 (24.9) 833 (24.1)
 4 482 (27.6) 824 (23.8)
 Unknown 37 (2.1) 59 (1.7)
Family history (chart audit)‡ 115 (6.6) 202 (5.8)
Primary care outpatient visits§
 0 83 (4.8) 71 (2.1)
 1 45 (2.6) 50 (1.4)
 2 96 (5.5) 110 (3.2)
 3+ 1523 (87.2) 3227 (93.3)
Charlson score at beginning of observation window
 0 1184 (67.8) 2626 (75.9)
 1 293 (16.8) 461 (13.3)
 2+ 268 (15.3) 369 (10.7)
 Unknown 2 (0.1) 4 (0.1)
Screening sigmoidoscopy 365 (20.9) 1030 (29.8)
Screening faecal occult blood test 702 (40.2) 1542 (44.6)

*The age at time of diagnosis, the date used to assess exposure and covariate information is shown.

†Data were obtained from the 2000 US Census data at the tract level.

‡Patients for whom the family history of colorectal cancer documented during the observation period did not meet the exclusion criteria. The exclusion was based on a history of colorectal cancer in one or more first-degree relatives before age 50 or in two or more second-degree relatives at any age, or other familial colorectal cancer syndromes.

§Defined based on outpatient clinical visits to family practice, gerontology/geriatrics, internal medicine, obstetrics/gynaecology and “primary care” clinics.